02/14/2025
1:36 PM | BB BIOTECH AG (Filed by)
Black Diamond Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/31/2025
3:35 PM | Black Diamond Therapeutics (Issuer)
Hatzis-Schoch Brent (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:35 PM | Black Diamond Therapeutics (Issuer)
Jones Erika (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:36 PM | Black Diamond Therapeutics (Issuer)
Buck Elizabeth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:36 PM | Black Diamond Therapeutics (Issuer)
Yurasov Sergey (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2025
3:37 PM | Black Diamond Therapeutics (Issuer)
Velleca Mark A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:09 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:34 PM | Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
3:34 PM | Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/05/2024
6:01 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/05/2024
6:03 AM | Black Diamond Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
Get the Latest News and Ratings for BDTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Black Diamond Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
10/24/2024
1:02 PM | Black Diamond Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
09/23/2024
6:09 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/20/2024
3:24 PM | Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:24 PM | Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/20/2024
3:30 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:16 PM | Black Diamond Therapeutics (Issuer)
Versant Vantage I, L.P. (Reporting)
Versant Venture Capital VI, L.P. (Reporting)
Versant Voyageurs I Parallel, L.P. (Reporting)
Versant Voyageurs I, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
3:48 PM | Black Diamond Therapeutics (Subject)
Versant Venture Capital VI, L.P. (Filed by)
| Form SC 13D/A | |
08/06/2024
6:00 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/06/2024
6:04 AM | Black Diamond Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/26/2024
4:54 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2024
3:51 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024
3:31 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
1:17 PM | Black Diamond Therapeutics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SC 13G/A | |
07/09/2024
3:30 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
4:44 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2024
4:06 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/24/2024
4:09 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2024
3:41 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2024
3:25 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
3:28 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:28 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
3:39 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024
3:11 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
3:12 PM | Black Diamond Therapeutics (Subject)
Epstein David M. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2024
5:20 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:50 PM | Black Diamond Therapeutics (Issuer)
Dhingra Kapil (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:52 PM | Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:53 PM | Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:54 PM | Black Diamond Therapeutics (Issuer)
Menzel Garry E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:55 PM | Black Diamond Therapeutics (Issuer)
Kulkarni Samarth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
05/13/2024
6:09 PM | Black Diamond Therapeutics (Subject)
New Enterprise Associates 16, L.P. (Filed by)
| Form SC 13D/A | |
05/09/2024
7:48 PM | Black Diamond Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13D/A | |
05/09/2024
6:10 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:13 AM | Black Diamond Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
3:04 PM | Black Diamond Therapeutics (Filer)
| Form ARS | |
04/12/2024
4:28 PM | Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:29 PM | Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/12/2024
4:27 PM | Black Diamond Therapeutics (Issuer)
Raman Prakash (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/12/2024
4:27 PM | Black Diamond Therapeutics (Issuer)
Campbell Shannon (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/12/2024
3:48 PM | Black Diamond Therapeutics (Filer)
| Form PRE 14A | |
04/11/2024
7:03 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
8:00 PM | Behbahani Ali (Reporting)
Black Diamond Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
7:49 PM | Black Diamond Therapeutics (Issuer)
DIXON WENDY L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2024
7:01 AM | Black Diamond Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/12/2024
6:17 AM | Black Diamond Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/12/2024
6:20 AM | Black Diamond Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/11/2024
12:14 PM | Black Diamond Therapeutics (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SC 13G/A | |
